Literature DB >> 26897515

Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.

.   

Abstract

PURPOSE/OBJECTIVE(S): We sought to identify swallowing muscle dose-response thresholds associated with chronic radiation-associated dysphagia (RAD) after IMRT for oropharyngeal cancer. MATERIALS/
METHODS: T1-4 N0-3 M0 oropharyngeal cancer patients who received definitive IMRT and systemic therapy were examined. Chronic RAD was coded as any of the following ⩾12months post-IMRT: videofluoroscopy/endoscopy detected aspiration or stricture, gastrostomy tube and/or aspiration pneumonia. DICOM-RT plan data were autosegmented using a custom region-of-interest (ROI) library and included inferior, middle and superior constrictors (IPC, MPC, and SPC), medial and lateral pterygoids (MPM, LPM), anterior and posterior digastrics (ADM, PDM), intrinsic tongue muscles (ITM), mylo/geniohyoid complex (MHM), genioglossus (GGM), masseter (MM), buccinator (BM), palatoglossus (PGM), and cricopharyngeus (CPM), with ROI dose-volume histograms (DVHs) calculated. Recursive partitioning analysis (RPA) was used to identify dose-volume effects associated with chronic-RAD, for use in a multivariate (MV) model.
RESULTS: Of 300 patients, 34 (11%) had chronic-RAD. RPA showed DVH-derived MHM V69 (i.e. the volume receiving⩾69Gy), GGM V35, ADM V60, MPC V49, and SPC V70 were associated with chronic-RAD. A model including age in addition to MHM V69 as continuous variables was optimal among tested MV models (AUC 0.835).
CONCLUSION: In addition to SPCs, dose to MHM should be monitored and constrained, especially in older patients (>62-years), when feasible.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dose–volume; Dysphagia; Geniohyoid; Intensity-modulated radiation therapy; Mylohyoid; Oropharyngeal cancer

Mesh:

Year:  2016        PMID: 26897515      PMCID: PMC4794433          DOI: 10.1016/j.radonc.2016.01.019

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  80 in total

1.  The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia.

Authors:  Ivo Beetz; Roel J H M Steenbakkers; Olga Chouvalova; Charles R Leemans; Patricia Doornaert; Bernard F A M van der Laan; Miranda E M C Christianen; Arjan Vissink; Henk P Bijl; Peter van Luijk; Johannes A Langendijk
Journal:  Acta Oncol       Date:  2013-09-02       Impact factor: 4.089

2.  Identifying early dehydration risk with home-based sensors during radiation treatment: a feasibility study on patients with head and neck cancer.

Authors:  Susan K Peterson; Eileen H Shinn; Karen Basen-Engquist; Wendy Demark-Wahnefried; Alexander V Prokhorov; Chaitanya Baru; Ingolf H Krueger; Emilia Farcas; Philip Rios; Adam S Garden; Beth M Beadle; Kai Lin; Yan Yan; Stephanie L Martch; Kevin Patrick
Journal:  J Natl Cancer Inst Monogr       Date:  2013-12

Review 3.  Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.

Authors:  Vinidh Paleri; Justin W G Roe; Primož Strojan; June Corry; Vincent Grégoire; Marc Hamoir; Avraham Eisbruch; William M Mendenhall; Carl E Silver; Alessandra Rinaldo; Robert P Takes; Alfio Ferlito
Journal:  Head Neck       Date:  2013-07-04       Impact factor: 3.147

4.  Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy.

Authors:  Qiuling Shi; Tito R Mendoza; G Brandon Gunn; Xin Shelley Wang; David I Rosenthal; Charles S Cleeland
Journal:  Qual Life Res       Date:  2013-03-09       Impact factor: 4.147

5.  Radiation dose to the floor of mouth muscles predicts swallowing complications following chemoradiation in oropharyngeal squamous cell carcinoma.

Authors:  Rachit Kumar; Sara Madanikia; Heather Starmer; Wuyang Yang; Emi Murano; Sara Alcorn; Todd McNutt; Yi Le; Harry Quon
Journal:  Oral Oncol       Date:  2013-11-12       Impact factor: 5.337

6.  Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer.

Authors:  M Haderlein; S Semrau; O Ott; S Speer; C Bohr; R Fietkau
Journal:  Strahlenther Onkol       Date:  2014-02       Impact factor: 3.621

7.  Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Linda S Elting; Thomas A Buchholz; K Kian Ang; Adam S Garden; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2014-01-13       Impact factor: 6.860

8.  Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.

Authors:  Klaudia U Hunter; Oliver E Lee; Teresa H Lyden; Marc J Haxer; Felix Y Feng; Mathew Schipper; Francis Worden; Mark E Prince; Scott A McLean; Gregory T Wolf; Carol R Bradford; Douglas B Chepeha; Avraham Eisbruch
Journal:  Head Neck       Date:  2013-06-01       Impact factor: 3.147

9.  Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck.

Authors:  Katherine A Hutcheson; Jan S Lewin; F Christopher Holsinger; Ganene Steinhaus; Asher Lisec; Denise A Barringer; Heather Y Lin; Sandra Villalobos; Adam S Garden; Vali Papadimitrakopoulou; Merrill S Kies
Journal:  Head Neck       Date:  2013-06-18       Impact factor: 3.147

10.  Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients.

Authors:  Goutham Hassan Venkatesh; Vadhiraja Bejadi Manjunath; Kamalesh Dattaram Mumbrekar; Hitendra Negi; Donald Jerard Fernandes; Krishna Sharan; Sourjya Banerjee; Satish Rao Bola Sadashiva
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more
  32 in total

1.  Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating.

Authors: 
Journal:  Radiother Oncol       Date:  2019-01-14       Impact factor: 6.280

2.  Modeling symptom drivers of oral intake in long-term head and neck cancer survivors.

Authors:  Mona Kamal; Martha P Barrow; Jan S Lewin; Alicia Estrella; G Brandon Gunn; Quiling Shi; Theresa M Hofstede; David I Rosenthal; Clifton David Fuller; Katherine A Hutcheson
Journal:  Support Care Cancer       Date:  2018-09-14       Impact factor: 3.603

3.  Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.

Authors:  Katherine A Hutcheson; Zhannat Nurgalieva; Hui Zhao; Gary B Gunn; Sharon H Giordano; Mihir K Bhayani; Jan S Lewin; Carol M Lewis
Journal:  Head Neck       Date:  2018-12-07       Impact factor: 3.147

4.  Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.

Authors: 
Journal:  Radiother Oncol       Date:  2017-07-18       Impact factor: 6.280

Review 5.  A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.

Authors:  Stefano Ursino; Elisa D'Angelo; Rosario Mazzola; Anna Merlotti; Riccardo Morganti; Agostino Cristaudo; Fabiola Paiar; Daniela Musio; Daniela Alterio; Almalina Bacigalupo; Elvio Grazioso Russi; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2017-06-14       Impact factor: 3.621

Review 6.  Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer.

Authors:  Janice Cho; Daniel E Johnson; Jennifer R Grandis
Journal:  Semin Radiat Oncol       Date:  2018-01       Impact factor: 5.934

Review 7.  Treatment of late sequelae after radiotherapy for head and neck cancer.

Authors:  Primož Strojan; Katherine A Hutcheson; Avraham Eisbruch; Jonathan J Beitler; Johannes A Langendijk; Anne W M Lee; June Corry; William M Mendenhall; Robert Smee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Cancer Treat Rev       Date:  2017-07-18       Impact factor: 12.111

8.  Risk and Rate of Occult Contralateral Nodal Disease in Surgically Treated Patients With Human Papillomavirus-Related Squamous Cell Carcinoma of the Base of the Tongue.

Authors:  Aisling S Last; Patrik Pipkorn; Stephanie Chen; Dorina Kallogjeri; Joseph Zenga; Jason T Rich; Randal Paniello; Jose Zevallos; Rebecca Chernock; Douglas Adkins; Peter Oppelt; Hiram Gay; Mackenzie Daly; Wade Thorstad; Ryan S Jackson
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-01-01       Impact factor: 6.223

9.  Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.

Authors:  Pierre Blanchard; Andrew J Wong; G Brandon Gunn; Adam S Garden; Abdallah S R Mohamed; David I Rosenthal; Joseph Crutison; Richard Wu; Xiaodong Zhang; X Ronald Zhu; Radhe Mohan; Mayankkumar V Amin; C David Fuller; Steven J Frank
Journal:  Radiother Oncol       Date:  2016-09-15       Impact factor: 6.280

10.  Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors.

Authors:  Katherine A Hutcheson; Martha P Barrow; Carla L Warneke; Yiqun Wang; George Eapen; Stephen Y Lai; Denise A Barringer; Emily K Plowman; Jan S Lewin
Journal:  Laryngoscope       Date:  2017-11-08       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.